Literature DB >> 15598566

13-Deoxytedanolide, a marine sponge-derived antitumor macrolide, binds to the 60S large ribosomal subunit.

Shinichi Nishimura1, Shigeki Matsunaga, Minoru Yoshida, Hiroshi Hirota, Shigeyuki Yokoyama, Nobuhiro Fusetani.   

Abstract

13-Deoxytedanolide is a potent antitumor macrolide isolated from the marine sponge Mycale adhaerens. In spite of its remarkable activity, the mode of action of 13-deoxytedanolide has not been elucidated. [11-3H]-(11S)-13-Deoxydihydrotedanolide derived from the macrolide was used for identifying the target molecule from the yeast cell lysate. Fractionation of the binding protein revealed that the labeled 13-deoxytedanolide derivative strongly bound to the 80S ribosome as well as to the 60S large subunit, but not to the 40S small subunit. In agreement with this observation, 13-deoxytedanolide efficiently inhibited the polypeptide elongation. Interestingly, competition studies demonstrated that 13-deoxytedanolide shared the binding site on the 60S large subunit with pederin and its marine-derived analogues. These results indicate that 13-deoxytedanolide is a potent protein synthesis inhibitor and is the first macrolide to inhibit the eukaryotic ribosome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15598566     DOI: 10.1016/j.bmc.2004.10.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Garbled messages and corrupted translations.

Authors:  Tilman Schneider-Poetsch; Takeo Usui; Daisuke Kaida; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

2.  Stereochemically versatile synthesis of the C1-C12 fragment of tedanolide C.

Authors:  Thomas E Smith; Sarah J Fink; Zebulon G Levine; Kerani A McClelland; Adrian A Zackheim; Mary E Daub
Journal:  Org Lett       Date:  2012-02-29       Impact factor: 6.005

3.  Myriaporone 3/4 structure--activity relationship studies define a pharmacophore targeting eukaryotic protein synthesis.

Authors:  John Hines; Myriam Roy; Hua Cheng; Christina M Agapakis; Richard Taylor; Craig M Crews
Journal:  Mol Biosyst       Date:  2006-05-26

4.  New candidaspongiolides, tedanolide analogues that selectively inhibit melanoma cell growth.

Authors:  Emily L Whitson; Kristen M Pluchino; Matthew D Hall; James B McMahon; Tawnya C McKee
Journal:  Org Lett       Date:  2011-06-06       Impact factor: 6.005

5.  Total synthesis of pederin and analogues.

Authors:  Fanghui Wu; Michael E Green; Paul E Floreancig
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-22       Impact factor: 15.336

6.  Enantioselective synthesis of the C1-C11 fragment of tedanolide C.

Authors:  Julie G Geist; Roland Barth; William R Roush
Journal:  Org Lett       Date:  2012-12-18       Impact factor: 6.005

7.  Total syntheses of (+)-tedanolide and (+)-13-deoxytedanolide.

Authors:  Joshua R Dunetz; Lisa D Julian; Jason S Newcom; William R Roush
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

Review 8.  Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.

Authors:  Alejandro M S Mayer; Kirk R Gustafson
Journal:  Eur J Cancer       Date:  2008-08-11       Impact factor: 9.162

9.  Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia.

Authors:  Tamara L Meragelman; Richard H Willis; Girma M Woldemichael; Andrew Heaton; Peter T Murphy; Kenneth M Snader; David J Newman; Rob van Soest; Michael R Boyd; John H Cardellina; Tawnya C McKee
Journal:  J Nat Prod       Date:  2007-06-12       Impact factor: 4.050

10.  Structures of triacetyloleandomycin and mycalamide A bind to the large ribosomal subunit of Haloarcula marismortui.

Authors:  Güliz Gürel; Gregor Blaha; Thomas A Steitz; Peter B Moore
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.